Literature DB >> 19568714

Anti-inflammatory mechanism of total glycosides of Acanthopanax Giraldii.

Fang Yuan1, Jie Chen, Guo-min Xu, Jia-jia Zheng, Qi-cai Long.   

Abstract

OBJECTIVE: To study the anti-inflammatory mechanisms of total glycosides of Acanthopanax Giraldii (TGA).
METHODS: The changes of prostaglandin E(2)(PGE(2)), tumor necrosis factor (TNF-alpha), nitric oxide (NO), and expressions of COX-1 mRNA and COX-2 mRNA in BALB/c mouse macrophages were observed by the radioimmunoassay, ELISA and nitric acid reduction and RT-PCR in the presence or absence of TGA.
RESULTS: (1) TGA could significantly decrease the production of PGE(2)and NO in mouse peritoneal macrophages. The inhibitory rate to LPS-induced PGE(2)production was 87% (TGA 100 mg/L, P<0.05, vs. LPS) and 62% (TGA 20 mg/L, P<0.05, vs. LPS), respectively. The inhibitory rate of NO production in mouse peritoneal macrophages was 49% (TGA 100 mg/L, P<0.05, vs. LPS) and 21% (TGA 20 mg/L, P<0.05 vs. LPS), respectively. TGA could not inhibit LPS-induced TNF-alpha production in mouse peritoneal macrophages. (2) TGA also inhibited the expression of COX-1 and COX-2 mRNA in RAW264.7 cells. The inhibitory rate of TGA to COX-1 mRNA was 22% (TGA 100 mg/L, P<0.05, vs. blank). The inhibitory rate of TGA to COX-2 mRNA was 55% (TGA 20 mg/L, P<0.05, vs. LPS) and 100% (TGA 100 mg/L, P<0.01 vs. LPS), respectively.
CONCLUSION: The anti-inflammatory mechanisms of TGA for inhibiting the production of NO and PGE(2)are through inhibiting COX-2 mRNA expression without TNF-alpha changes.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19568714     DOI: 10.1007/s11655-009-0210-0

Source DB:  PubMed          Journal:  Chin J Integr Med        ISSN: 1672-0415            Impact factor:   1.978


  15 in total

1.  Prostaglandin E2 promotes degranulation-independent release of MCP-1 from mast cells.

Authors:  Takayuki Nakayama; Noriko Mutsuga; Lei Yao; Giovanna Tosato
Journal:  J Leukoc Biol       Date:  2005-11-07       Impact factor: 4.962

2.  Lipopolysaccharide priming of alveolar macrophages for enhanced synthesis of prostanoids involves induction of a novel prostaglandin H synthase.

Authors:  M G O'Sullivan; F H Chilton; E M Huggins; C E McCall
Journal:  J Biol Chem       Date:  1992-07-25       Impact factor: 5.157

3.  Effects of Tripterygium wilfordii hook F extracts on induction of cyclooxygenase 2 activity and prostaglandin E2 production.

Authors:  X Tao; H Schulze-Koops; L Ma; J Cai; Y Mao; P E Lipsky
Journal:  Arthritis Rheum       Date:  1998-01

Review 4.  Cytokines and cytokine inhibitors or antagonists in rheumatoid arthritis.

Authors:  W P Arend; J M Dayer
Journal:  Arthritis Rheum       Date:  1990-03

5.  Inhibitory effect of 3,4-diaryl-3-pyrrolin-2-one derivatives on cyclooxygenase 1 and 2 in murine peritoneal macrophages.

Authors:  Fang Shen; Ai-Ping Bai; Zong-Ru Guo; Gui-Fang Cheng
Journal:  Acta Pharmacol Sin       Date:  2002-08       Impact factor: 6.150

Review 6.  Apoptosis as a therapeutic tool in rheumatoid arthritis.

Authors:  Richard M Pope
Journal:  Nat Rev Immunol       Date:  2002-07       Impact factor: 53.106

7.  Release of reactive nitrogen intermediates and reactive oxygen intermediates from mouse peritoneal macrophages. Comparison of activating cytokines and evidence for independent production.

Authors:  A H Ding; C F Nathan; D J Stuehr
Journal:  J Immunol       Date:  1988-10-01       Impact factor: 5.422

8.  Inhibition of lipopolysaccharide-inducible nitric oxide synthase, TNF-alpha and COX-2 expression by sauchinone effects on I-kappaBalpha phosphorylation, C/EBP and AP-1 activation.

Authors:  Ae Kyung Lee; Sang Hyun Sung; Young Choong Kim; Sang Geon Kim
Journal:  Br J Pharmacol       Date:  2003-05       Impact factor: 8.739

9.  Imrecoxib: a novel and selective cyclooxygenase 2 inhibitor with anti-inflammatory effect.

Authors:  Xiao-hong Chen; Jin-ye Bai; Fang Shen; Ai-ping Bai; Zong-ru Guo; Gui-fang Cheng
Journal:  Acta Pharmacol Sin       Date:  2004-07       Impact factor: 6.150

10.  The anti-inflammatory carbazole, LCY-2-CHO, inhibits lipopolysaccharide-induced inflammatory mediator expression through inhibition of the p38 mitogen-activated protein kinase signaling pathway in macrophages.

Authors:  Feng-Ming Ho; Chih-Chang Lai; Li-Jiau Huang; Tsun Cheng Kuo; Chien M Chao; Wan-Wan Lin
Journal:  Br J Pharmacol       Date:  2004-02-23       Impact factor: 8.739

View more
  1 in total

1.  HPTLC-profiling of eleutherosides, mechanism of antioxidative action of eleutheroside E1, the PAMPA test with LC/MS detection and the structure-activity relationship.

Authors:  Daniel Załuski; Rafał Kuźniewski; Zbigniew Janeczko
Journal:  Saudi J Biol Sci       Date:  2016-01-19       Impact factor: 4.219

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.